Do I Need a Pulmonary Hypertension Specialist for PAH?
At a Glance
People with suspected or diagnosed pulmonary arterial hypertension (PAH) should be evaluated at an experienced pulmonary hypertension center. Specialists can confirm the diagnosis, assess risk, tailor treatment, and coordinate shared care with local cardiologists or pulmonologists.
If you have been diagnosed with or are suspected to have pulmonary arterial hypertension (PAH), experts strongly recommend that you be evaluated by a pulmonary hypertension specialist at an experienced or accredited pulmonary hypertension center [1][2].
Pulmonary hypertension is a broad term for high blood pressure in the lungs, which can be caused by many different conditions (such as left-heart disease or lung disease). PAH is a specific, rare, and complex subtype—including idiopathic (unknown cause) and heritable forms—that requires highly specialized care. While your local cardiologist or pulmonologist plays a crucial role in your health, they may not manage PAH regularly. At an expert center, you will be treated by a team that specializes in this specific disease.
Why a Specialized Center Matters
Care at an accredited center provides several crucial advantages for managing your health:
- Comprehensive Diagnosis: Diagnosing PAH is complex. It involves excluding other causes of pulmonary hypertension through various noninvasive tests, followed by a right-heart catheterization [3]. This is a procedure where a thin tube is guided to your heart to measure the blood pressure in your lungs. A specialized team will use these results to confirm your diagnosis and ensure you receive the correct treatment [4].
- Risk Stratification: Specialists perform careful risk assessments to estimate the severity of your disease [5]. This is a clinical estimate based on your symptoms and test results that helps guide your treatment plan over time.
- Access to Advanced Therapies: Treatment for PAH is tailored to your specific risk level, symptoms, and the underlying cause. Guidelines often recommend a goal-oriented strategy that may involve combination therapy (taking two or three medications together) [1][6]. Physicians at specialized centers have more experience prescribing and managing advanced treatments [7]. For intermediate-high or high-risk patients, this may include parenteral prostacyclins—powerful continuous medications delivered directly into the vein or under the skin via a pump [8].
- Improved Outcomes: Studies show that early treatment with combination therapy and appropriate use of parenteral prostacyclins for high-risk patients are associated with significant improvements in outcomes [9][10]. Care at an expert center improves your access to timely diagnosis, tailored risk-based therapy, and necessary treatment escalations.
- A Multidisciplinary Team Approach: PAH care requires more than just a single doctor. Specialized centers offer a team that may include specialized PH nurses, pharmacists who coordinate complex medication access [11], genetic counselors (especially important for heritable PAH) [12], and social workers.
- Clinical Trials: Specialized centers are at the forefront of PAH research and provide access to clinical trials for new, experimental therapies [13][14].
- Transplant Evaluation: If your disease remains high-risk or responds inadequately to optimal therapy, specialized centers have the expertise to refer you for a lung transplant evaluation [15]. This evaluation is an assessment and planning process—not a commitment to surgery—and early referral ensures you have the most options available.
Important Safety Warning
If you are prescribed continuous parenteral prostacyclins via a pump, never stop or interrupt these medications abruptly. A pump, line, or infusion interruption is a medical emergency. You should follow your center’s individualized emergency plan.
Seek immediate emergency medical help if you experience:
- Fainting or near-fainting
- Severe or rapidly worsening shortness of breath
- New or worsening chest pain
- Confusion
- Blue or gray tint to your lips
Can I Still See My Local Cardiologist?
Many patients prefer local care because traveling to a specialized center can be difficult or expensive. The good news is that you often do not have to choose one over the other.
An excellent option for many patients is a shared-care approach (also known as co-management) [16]. Under this individualized arrangement, your PAH specialist at the comprehensive center may design your treatment plan, prescribe specialized medications, and perform complex procedures [4]. Your local cardiologist or pulmonologist can then help monitor your condition, handle routine check-ups, and manage other general health issues.
For shared care to work safely, you need a clearly documented plan that includes direct communication between your local doctor and your specialist, as well as an emergency action plan [17].
If you are diagnosed with or suspected to have PAH, do not hesitate to ask for a referral to a pulmonary hypertension center. Securing an expert care team early is one of the most important steps you can take.
Common questions in this guide
Why should I see a pulmonary hypertension specialist for PAH?
Can my local cardiologist or pulmonologist still care for me?
What happens at a pulmonary hypertension center?
Does seeing a PAH specialist mean I will need a lung transplant?
When should I seek emergency help with PAH?
Can a PAH specialist help me access advanced treatments or research?
Should people with PAH consider genetic counseling?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Choosing a specialist
Should I be evaluated at a pulmonary hypertension center for PAH?
Local care options
Can my local cardiologist still help with my care through a shared-care approach?
Treatment options
Would combination therapy be part of my PAH treatment plan?
Related questions
Show more
Get notified when new evidence is published on Idiopathic/heritable pulmonary arterial hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Recent Advances in the Diagnosis and Management of Pulmonary Arterial Hypertension.
Mullen E, McCullagh B, Gaine S, Quadery SR
British journal of hospital medicine (London, England : 2005) 2025; (86(2)):1-13 doi:10.12968/hmed.2024.0635.
PMID: 39998132 - 2
[Advances in pulmonary hypertension diagnosis and risk stratification].
Maloir Q, Petitjean H, Parzibut G, et al.
Revue medicale de Liege 2023; (78(2)):99-106.
PMID: 36799327 - 3
Diagnosis and management of pulmonary arterial hypertension.
Cullivan S, Higgins M, Gaine S
Breathe (Sheffield, England) 2022; (18(4)):220168 doi:10.1183/20734735.0168-2022.
PMID: 36865939 - 4
Pulmonary Arterial Hypertension: Recognition and Management in Primary and Acute Care Settings.
Ahern BJ, Fulford ST, Long D, Miller CL
Cureus 2025; (17(12)):e100073 doi:10.7759/cureus.100073.
PMID: 41583269 - 5
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A, Weatherald J, Savale L, et al.
The European respiratory journal 2017; (50(2)) doi:10.1183/13993003.00889-2017.
PMID: 28775050 - 6
Management of Pulmonary Arterial Hypertension.
Weatherald J, Varughese RA, Liu J, Humbert M
Seminars in respiratory and critical care medicine 2023; (44(6)):746-761 doi:10.1055/s-0043-1770118.
PMID: 37369218 - 7
Clinical Practice of Pulmonary Arterial Hypertension (PAH) and Potential Barriers to Intensive Treatment Among PAH-Specialized and Non-PAH-Specialized Centers in Japan.
Arai Y, Zhang W, Yamauchi S, et al.
Pulmonary circulation 2026; (16(3)):e70351 doi:10.1002/pul2.70351.
PMID: 42524152 - 8
Pulmonary arterial hypertension.
Boucly A, Gerges C, Savale L, et al.
Presse medicale (Paris, France : 1983) 2023; (52(3)):104168 doi:10.1016/j.lpm.2023.104168.
PMID: 37516248 - 9
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
Boucly A, Savale L, Jaïs X, et al.
American journal of respiratory and critical care medicine 2021; (204(7)):842-854 doi:10.1164/rccm.202009-3698OC.
PMID: 34185620 - 10
Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes.
Burger CD, Ghandour M, Padmanabhan Menon D, et al.
ClinicoEconomics and outcomes research : CEOR 2017; (9()):731-739 doi:10.2147/CEOR.S119117.
PMID: 29200882 - 11
Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications.
Martirosov AL, Smith ZR, Hencken L, et al.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2020; (77(12)):958-965 doi:10.1093/ajhp/zxaa079.
PMID: 32495842 - 12
Genetics of pulmonary hypertension in the clinic.
Girerd B, Lau E, Montani D, Humbert M
Current opinion in pulmonary medicine 2017; (23(5)):386-391 doi:10.1097/MCP.0000000000000414.
PMID: 28661905 - 13
Pulmonary Hypertension Care Center Network: Improving Care and Outcomes in Pulmonary Hypertension.
Sahay S, Melendres-Groves L, Pawar L, et al.
Chest 2017; (151(4)):749-754 doi:10.1016/j.chest.2016.10.043.
PMID: 27818333 - 14
Treatment of pulmonary arterial hypertension: recent progress and a look to the future.
Humbert M, Sitbon O, Guignabert C, et al.
The Lancet. Respiratory medicine 2023; (11(9)):804-819 doi:10.1016/S2213-2600(23)00264-3.
PMID: 37591298 - 15
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.
Hoeper MM, Benza RL, Corris P, et al.
The European respiratory journal 2019; (53(1)) doi:10.1183/13993003.01906-2018.
PMID: 30545979 - 16
Managing the Patient with Pulmonary Hypertension: Specialty Care Centers, Coordinated Care, and Patient Support.
Chakinala MM, Duncan M, Wirth J
Cardiology clinics 2016; (34(3)):489-500.
PMID: 27443143 - 17
The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.
Price LC, Dimopoulos K, Marino P, et al.
Thorax 2017; (72(11)):1035-1045 doi:10.1136/thoraxjnl-2016-209725.
PMID: 28904006
This page is for informational purposes only and does not constitute medical advice. If you have suspected or diagnosed PAH, ask your cardiologist or pulmonologist about referral and follow your specialist center’s emergency plan.